[Form 4] Marvell Technology, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Insider grant and filing summary: Justin Scarpulla, SVP and Chief Accounting Officer of Marvell Technology, Inc. (MRVL), reported a grant of 12,662 restricted stock units (RSUs) on 08/18/2025. Each RSU converts to one common share upon vesting. The award vests over four years with 25% scheduled to vest on August 15, 2026 and the remainder vesting quarterly thereafter until fully vested. The Form 4 was filed indicating a direct beneficial ownership of 12,662 shares following the grant and was signed by an attorney-in-fact on 08/20/2025.

Insights

Financial Analyst

TL;DR: Routine executive RSU grant to align compensation with retention and performance, reported timely on Form 4.

The reported 12,662 RSU award represents a typical equity-based compensation award for a senior officer and vests over four years, supporting retention. The grant is documented as direct beneficial ownership of 12,662 shares upon vesting and the zero price indicates these are time-based/contingent RSUs rather than open-market purchases. No cash consideration or derivative transactions are reported. This disclosure is procedural and carries no immediate cash impact on the issuer.

Corporate Governance Expert

TL;DR: Standard long-term incentive grant with a multi-year vesting schedule; disclosure meets Section 16 reporting requirements.

The grant's four-year vesting with an initial 25% cliff followed by quarterly vesting is a common governance practice to promote executive retention and align interests with shareholders. The Form 4 lists the relationship as officer and specifies direct ownership; the filing was executed by an attorney-in-fact and dated promptly. There are no indications of related-party sales, option exercises, or hedging arrangements disclosed in this filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Scarpulla Justin

(Last) (First) (Middle)

5488 MARVELL LANE

(Street)

SANTA CLARA CA 95054

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Marvell Technology, Inc. [ MRVL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	08/18/2025		A		12,662		(2)	(2)	Common Stock	12,662	$0	12,662	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one Marvell Technology, Inc. common share upon vesting.

2. Grant vests over 4 years with 25% of the shares vesting on August 15, 2026 then the remaining shares vesting quarterly thereafter until fully vested.

Remarks:

	Justin Scarpulla by Blair Walters as Attorney-in-Fact	08/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Marvell insider Justin Scarpulla report on Form 4 (MRVL)?

The Form 4 reports a grant of 12,662 restricted stock units (RSUs) to Justin Scarpulla dated 08/18/2025.

How do the 12,662 RSUs vest for MRVL insider Justin Scarpulla?

The RSUs vest over four years with 25% vesting on August 15, 2026 and the remaining shares vesting quarterly thereafter until fully vested.

Does the Form 4 show any purchase price for the RSUs?

The filing shows a price of $0, indicating these are contingent restricted stock units, not open-market purchases.

Who filed the Form 4 and when was it signed?

The form was signed by Justin Scarpulla by Blair Walters as Attorney-in-Fact and dated 08/20/2025.

What is the reported ownership after the transaction?

The filing reports 12,662 shares of common stock as beneficially owned following the reported RSU grant.

What role does Justin Scarpulla hold at Marvell (MRVL)?

The Form 4 identifies him as SVP, Chief Accounting Officer and an officer of the issuer.